Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Biosimilar infliximab administration for the management of acute graft-versus-host disease.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Biosimilar infliximab administration for the management of acute graft-versus-host disease.
Biosimilar infliximab administration for the management of acute graft-versus-host disease. J Oncol Pharm Pract. 2020 Dec; 26(8):2047-2051.
View in:
PubMed
subject areas
Acute Disease
Adult
Biosimilar Pharmaceuticals
Female
Graft vs Host Disease
Hematopoietic Stem Cell Transplantation
Humans
Infliximab
Male
Middle Aged
Tumor Necrosis Factor-alpha
authors with profiles
Sunita Nathan